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Abstract
Background: Total nutrient intake (TNI) is intake from food and supple-
ments. This provides an assessment of nutrient adequacy and the prevalence
of excessive intake, as well as the response with respect to biomarkers. Cod
liver oil (CLO) is the most frequently consumed supplement in the UK,
containing nutrients that might have varying influences on health. We cal-
culated TNI for vitamins A, D and E, as well as eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), and assessed associations with the
respective blood concentrations.
Methods: Seven-day diet diaries and blood samples were taken from two
subsets of the European Prospective Investigation into Cancer (EPIC-Nor-
folk) cohort (age range 39–79 years; n = 1400 for vitamin D; n = 6656 for
remaining nutrients). TNI was calculated for the subgroups: nonsupplement
users, those consuming the nutrient in supplement form and those consum-
ing a supplement without this nutrient.
Results: CLO-related nutrients were supplemented by 15%–33%, which
approximately doubled median intakes. Almost everyone in the supplement
+ vitamin A group reached the estimated average requirement; however,
guideline levels were likely to be exceeded. Partial correlations between
intake of vitamins A and D and biomarkers were low and modestly
strengthened by the inclusion of supplement sources (correlation = 0.01–
0.13). Correlations between biomarker and TNI of vitamin E and
EPA+DHA were in the range 0.40–0.46; however, vitamin E exceeding food
intake resulted in attenuated coefficients. Linear associations between food
or TNI EPA+DHA and plasma were weak but consistent across subgroups.
Conclusions: CLO-related nutrients contribute substantially to nutrient
intake, with a risk of over-consumption. Apart from EPA+DHA, biomarker
data suggest that CLO-related nutrients in supplements are not linearly
associated with vitamin status.
Introduction
In the European Prospective Investigation into Cancer
and Nutrition in Norfolk (EPIC-Norfolk), a population-
based cohort in the UK, dietary supplements are used by
32% of men and 45% of women (Lentjes et al., 2013),
with cod liver oil (CLO) being consumed most frequently
(Lentjes et al., 2011). The Vitamin and Mineral Supple-
ment (ViMiS) database and software that have been
developed enable the assessment of combined food and
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supplement intake into total nutrient intake (TNI) (Lent-
jes et al., 2011). Knowing the TNI has three advantages.
First, a comparison of TNI with average requirements
and upper limits can better identify groups at risk of
inadequate or excessive intakes. For example, the poten-
tial harmful aspects of an excessive intake of vitamins A
and D can only be assessed when both food and supple-
ment sources are quantified (Expert group on vitamins &
minerals, 2003). Second, associations with nutrient intake
and blood biomarkers could become stronger and provide
better insight into the diet-biomarker-disease association.
Third, associations of nutrient exposure and biomarkers
are not linear (e.g. vitamin E) (White et al., 2001; Lebold
et al., 2012). The association is not apparent unless the
full range of intake is assessed; for example, by including
supplement sources (Vogel et al., 1997).
UK studies (Kirk et al., 1999; McNaughton et al., 2005)
report that supplement users (SU) have higher energy,
macro- and micronutrient intakes from food alone than
nonsupplement users (NSU) and the National Diet and
Nutrition Survey (NDNS) shows that, at the population
level, supplement use has an impact on the proportions
reaching the reference nutrient intake (Henderson et al.,
2003). However, a comparison of all SU together, disre-
garding the type of supplement, and hence which nutrient
a SU adds to their diet, may introduce errors in the expo-
sure measurements. This might be particularly important
where the range of safe nutrient intake is relatively narrow
(e.g. for retinol) (Mulholland & Benford, 2007).
Cohort studies relating CLO-related nutrient intake to
biomarker data have reported that vitamin E intake has
positive correlation coefficients with plasma a-tocoph-
erol, ranging from 0.40 (food source) to 0.69 (TNI) (Vo-
gel et al., 1997; White et al., 2001; Satia-Abouta et al.,
2003; Lebold et al., 2012), whereas it has negative corre-
lations with c-tocopherol, ranging from 0.04 (food) to
0.54 (TNI) (Vogel et al., 1997; White et al., 2001; Le-
bold et al., 2012). Trial data show associations between
intake and respective blood biomarkers of eicosapentae-
noic acid (EPA) and docosahexaenoic acid (DHA) (Ar-
terburn et al., 2006). Spearman correlations between TNI
and plasma in observational studies were in the range
0.53–0.58 (Hjartaker et al., 1997), with lower correlations
between food sources only and plasma in the range
0.23–0.29 (Astorg et al., 2008). Although 25–hydroxy
cholecalciferol is mainly produced in the skin under
influence of sunlight, a 10 nmol L1 higher concentra-
tion has been found among participants using low-dose
(5 lg day1) supplements (Hypp€onen & Power, 2007).
In the UK, where CLO is the most common dietary sup-
plement (Henderson et al., 2002), all of these nutrients
are provided in a single capsule, raising concerns about
collinearity when aiming to examine associations
between single nutrients and outcomes (Patterson et al.,
1997), although this also enables the assessment of
possible synergistic effects on plasma concentrations (e.g.
omega-3 fatty acids and vitamin E) (Institute of
Medicine, 2000).
The analyses extend on the analogy used by Block et al.
(1994) regarding the quantification of cigarette smoking
and nutrient intake: one would not calculate the average
amount of cigarettes smoked for the population as a
whole, rather only that for smokers. Hence, rather than
comparing all SU versus NSU, we describe the contribu-
tion of CLO and nutrient-related supplements to nutrient
exposure by the nutrient supplemented and the effect that
supplements have on the prevalence of adequate and
excessive nutrient intake. Additionally, we analysed the
association between nutrient intake, from both food and
TNI, and respective blood biomarkers as surrogate indica-
tors of absorption and metabolism in a population where
only a minority use single, high-dose supplements.
Materials and methods
Study design
EPIC-Norfolk is a prospective cohort study into the
determinants of health and chronic diseases (Day et al.,
1999). The study was approved by the Norwich District
Health Authority Ethics Committee and participants pro-
vided their written informed consent. The first round of
data collection started in 1993 and finished in 1998. The
study recruited 30 445 participants, of whom 25 639
attended a health examination at their general practi-
tioner’s practice. A trained nurse measured participant’s
height (cm) and weight (kg) and obtained a blood sam-
ple.
Blood analysis
A 42-mL sample of blood was taken in nonfasting state
(Day et al., 1999). Blood was collected in citrated and
plain monovettes and stored in a refrigerator. The next
day, blood samples were processed and stored at
196 °C as plasma and serum. Serum cholesterol was
determined for the full cohort in a Norfolk laboratory
using a RA 1000 Diagnostics (Bayer, Basingstoke, UK)
instrument, and cohort concentrations ranged from 2.10–
12.40 mmol L1. The remainder of the blood samples
were analysed on subsets of participants (Table 1). Serum
25-hydroxy cholecalciferol [25(OH)D3] and ergocalciferol
[25(OH)D2] were determined as part of a nested case–
cohort study that consisted of 892 participants with inci-
dent type 2 diabetes and a random sample (n = 989)
of the EPIC-Norfolk cohort (Forouhi et al., 2012).
Ultra-performance liquid chromatography-tandem mass
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spectrometry was used to measure serum concentrations,
using a standardised assay. Measured concentrations ran-
ged from 9.48–163.74 nmol L1 for 25(OH)D3 and from
0.25–24.21 nmol L1 for 25(OH)D2 [we excluded both
concentrations for one participant who had a 25(OH)D2
concentration of 45 nmol L1]. The vitamins retinol and
a- and c-tocopherol, as well as the omega-3 fatty acids
EPA and DHA, were analysed on a participant subset that
consisted of a series of previous case–control studies,
where cases were defined by incident cardiovascular dis-
ease or cancer and four matched, disease-free controls.
Plasma concentrations were analysed at IARC, Lyon
(France) using high-performance liquid chromatography
for the vitamins [concentrations in the range: retinol
0.27–5.29 lmol L1, a-tocopherol 3.36–100.58 lmol L1
and c-tocopherol 0.07–9.54 lmol L1; we excluded one
participant for whom c-tocopherol was greater than
a-tocopherol (ratio <1), as well as two participants where
this ratio was >1000 (where the remainder of the ratios
reached a maximum of 522)]. Gas chromatography was
used to analyse concentrations of the fatty acids (ranging
from 47–1707 lmol L1). EPA and DHA were summed,
for both nutrient intake and plasma concentrations, aim-
ing to avoid issues surrounding retroconversion of DHA
to EPA (Arterburn et al., 2006).
Measuring dietary nutrient intake
The participants who came for a health examination
received a 7-day diet diary (7dDD). A nurse explained
the purpose of the 7dDD and took a 24-h diet recall to
ensure good quality of recording by the participant for
the remaining 6 days. The days were divided into eight
different potential meal occasions. Portions could be
quantified using household measures, packaging or any of
the 17 coloured photos. The 7dDD was completed by
25 507 participants, with 23 638 (92%) completing more
than 1 day. They were entered into bespoke software
[Data Into Nutrients for Epidemiological Research
(DINER)] (Welch et al., 2001) and checked by nutritionists
for completeness and consistency. Nutrient outliers were
identified and data-entry errors were corrected (Lentjes
et al., 2014).
Measuring supplement nutrient intake
Supplements were recorded by participants in the Back
of the Diary (BOD) (Lentjes et al., 2011). The ViMiS
database contained the nutrient analyses per unit of
consumption using supplement-specific manufacturers’
data. Where the participants did not record the supple-
ment data in sufficient detail, a weighted average of
available options was taken from the ViMiS database.
Missing values for EPA and DHA nutrient composition
were estimated from CLO supplements of similar type
(capsule versus liquid) and CLO content. Quantities of
vitamins and fatty acids were converted to match the
unit of food intake. The average daily nutrient intake
from supplements for each participant was calculated
and added to their average daily food intake to obtain
TNI. Participants were grouped into one of the three
subgroups:
• NSU: participants not consuming any supplement (the
nutrient intake was derived from food sources only);
• SU: participants consuming (a) supplement(s) but
this supplement did not contain the specific nutrient
being studied (the nutrient intake was derived from food
sources only);
• SU+: participants consuming (a) supplement(s) that
contained the specific nutrient being studied (the nutrient
intake was derived from food and supplement sources);
participants who consumed a supplement with a daily
nutrient intake below the set thresholds (i.e. supplement
intake below 5% of mean cohort intake from food
sources only), were considered SU rather than SU+, as
described in detail elsewhere (Lentjes et al., 2011).
Daily reference values
The daily reference values and upper levels for the vita-
mins studied were defined as:
• Estimated average requirement (EAR), used for com-
paring populations against a standard. It is the average
nutrient requirement in a group (COMA, 1991; Carriqui-
ry, 1999).
• Safe upper level (SUL), ‘represents an intake that can
be consumed daily over a lifetime without significant risk
to health on the basis of available evidence (Expert Group
on Vitamins and Minerals, 2003)’
• Guidance level (GL), ‘an approximate indication of
levels that would not be expected to cause adverse effect
but have been derived from limited data and are less
secure than SULs (Expert Group on Vitamins and Miner-
als, 2003)’
Statistical analysis
Only participants who attended the health examination,
who completed the BOD regarding dietary supplement
use, and for whom serum cholesterol was determined,
were included in the analysis (n = 1400 for vitamin D;
n = 6656 for the remaining nutrients). Cholesterol was
included, because plasma EPA, DHA and the fat-soluble
vitamins were adjusted for cholesterol. The characteristics
of the full cohort and the two subcohorts are given in
Table 1.
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Nutrient and plasma/serum concentrations were
described by supplement subgroup (NSU/SU/SU+).
These data were positively skewed; hence, Mann–Whitney
tests were used to test for differences in nutrient intake
and biomarker data between the subgroups [P < 0.017
(0.05/3) was considered statistically significant]. The pro-
portion in EPIC-Norfolk not meeting the EAR, or exceed-
ing the SUL or GL, was estimated, with and without
supplement sources. Similarly, proportions were given
below the deficiency concentration (0.7 lmol L1) of
plasma retinol (Vogel et al., 1997); three different serum
25(OH)D3 concentrations reflecting rickets prevention
(25 nmol L1), common laboratory reference value
for identifying low concentrations (40 nmol L1) and
concentrations suggested for optimal bone health
(75 nmol L1) (Hypp€onen & Power, 2007); and plasma
a-tocopherol concentrations needed to prevent hemolysis
(12 lmol L1) (Institute of Medicine, 2000).
The log10 transformed nutrient intake and its plasma
concentration were plotted (Figure S1). Linear asso-
ciations between intake and biomarker data were tested
per 800 lg day1 of retinol equivalent (RE) intake
(common supplement dose), per 5 lg day1 of vitamin
D intake (common supplement dose), per 10 mg day1
of a–TE (tocopherol equivalent) intake (common dose
in CLO and multivitamins/multiminerals supplements)
and per 100 mg of EPA and DHA intake (low-dose
range in capsules). Partial correlations are given (i.e.
associations between biomarker and nutrient intake from
food only and TNI), adjusted for common confounders
(Vogel et al., 1997; White et al., 2001; Arab, 2003). Vita-
min D was adjusted for energy intake (per MJ), season
(spring/summer versus autumn/winter), physical activity
[(moderately) active versus (moderately) inactive], age
(per 5 years) and body mass index (BMI) (per kg m–2).
Concentrations for plasma tocopherol and EPA+DHA
were log-transformed and these biomarkers, as well as
retinol, were adjusted for energy intake, serum total cho-
lesterol (per mmol L1), BMI, smoking (current versus
former/never), alcohol intake (per 8 g alcohol day1)
and age. Of the log-transformed biomarker data, the
exponent of the b was taken; the b coefficient therefore
represents a percentage change in plasma for a unit
change in intake [e.g. for every 10 mg of vitamin E
intake (x-axis), the mean percentage decrease in plasma
c-tocopherol that was observed (y-axis)]. Finally,
the effect of the modification of omega-3 fatty acid
concentrations by vitamin E intake was formally
tested by inserting an interaction term of CLO supple-
ments and vitamin E supplements using univariate
analysis of variance (ANCOVA). In other words, we tested
whether we could observe an additional increment in
plasma EPA+DHA when vitamin E was supplemented in
combination with CLO, as opposed to CLO supplemen-
tation on its own.
All analyses were performed stratified by sex and sub-
group of supplement use. Unless noted otherwise,
P < 0.05 was considered statistically significant. Statistical
analyses were conducted using SPSS, version 21 (IBM
Corp., Armonk, NY, USA).
Results
Proportion of supplement users
In men, 23.1% consumed CLO supplements; however,
the prevalences of those taking vitamin A, D and/or E
from any supplement sources were 26.5%, 23.2% and
14.8%, respectively (vitamin E was not present, or not
quantified by manufacturers in all CLO supplements).
Among women, CLO was taken by 26.3% and the preva-
lence of supplementation with vitamin A, D and/or E was
33.0%, 30.0% and 24.3%, respectively.
Distribution of food intake and total nutrient intake
The cumulative percentile distributions of nutrient intake
are shown in Figs 1–4. The median supplement dose in
the SU+ group for each decile in the food sourced distri-
bution did not show significant differences (data not
shown): median supplement intake of vitamin A was
750 lg RE day1; vitamin D was 3.22 lg day1 for men
to 2.76 lg day1 for women; vitamin E was 7.1 mg a–
TE day1 for men to 9.1 mg a–TE day1 for women;
and EPA+DHA was 0.09 g day1. Intake from food
sources showed small differences between the three sub-
groups, most of which were nonsignificant (Table 2). The
median TNI in the SU+ subgroup was 1.7- to 2.5-fold
higher compared to food sources only. For SU+A, the
increase in TNI led to a lower proportion of participants
not meeting the EAR and increased the proportion of
participants exceeding the GL from approximately 7–12%
to 28.1% for men and 23.6% for women. When only
considering preformed retinol from supplement sources,
these percentages were 5.4% and 5.5% respectively. Only
a few participants exceeded the SUL or GL for the other
CLO-related vitamins studied.
Associations between nutrient intake and biomarkers
There were no differences in serum/plasma concentrations
between the NSU and the SU groups (Table 2); how-
ever, with the exception of 25(OH)D2 and 25(OH)D3 in
men, all nutrient concentrations were up to 10% higher
in the SU+ group compared to the SU group for retinol
and a-tocopherol; and up to 25% higher for EPA+DHA
and 25(OH)D3 in women, although up to 22% lower for
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c-tocopherol. Participants in the SU+D group were less
likely to have serum 25(OH)D3 concentrations below the
various threshold levels commonly applied to identify
hypovitaminosis D. Participants with very low retinol and
a-tocopherol concentrations were not common in these
subcohorts.
The linear association and partial correlations of vita-
min intake with their respective (log-transformed)
plasma/serum concentration in the three supplement sub-
groups are presented in Table 3 (men) and Table 4
(women). Vitamin A and vitamin D intakes were weakly
correlated with blood retinol and 25(OH)D3, respectively.
In the SU+E group, the partial correlation greatly
increased for TNI versus food intake only, explaining
minimally 13% more of the variance of plasma tocophe-
rols. For a-tocopherol, the linear coefficients in the NSU
group were the highest, predicting a 13% and 16%
increase in plasma concentration for every 10-mg vitamin
E intake increment in men and women, respectively;
however, among SU+E, the linear association weakened
for both food (7% and 13%, respectively) and even more
so for TNI (1%). A similar, but opposite, effect on partial
correlation was observed for c-tocopherol. This analysis
was repeated for participants whose TNI did not exceed
17 mg day1, an intake below which 95% of the variance
in plasma can be explained by nutrient intake in vitamin
E depleted volunteers (Institute of Medicine, 2000). This
restriction resulted in stronger linear associations with a-
tocopherol in the SU+E group for TNI in women, at the
same time as substantially reducing the partial correla-
tions for TNI (compared to the full TNI range of intake
among SU+E). Associations between intake and c-
tocopherol became nonsignificant for men but strength-
ened in women. For EPA+DHA, the linear association
remained similar (2–4% increase in plasma per 100 mg
increase in intake) across all subcategories of SU, even
when supplement sources were included (TNI).
Finally, we tested for the interaction between vitamin E
and CLO supplement use and found that mean
EPA+DHA concentrations were significantly higher if
vitamin E was supplemented together with EPA+DHA
compared to EPA+DHA only (Fig. 5); however, its
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significance disappeared (P = 0.13) after adjusting for
TNI, indicating that the higher dose of EPA and DHA in
vitamin E containing CLO was mainly driving the higher
plasma EPA+DHA concentration.
Discussion
Nutrients related to CLO consumption were supple-
mented by 15% to 33% of the participants. Inclusion of
supplements resulted in approximately a doubled nutrient
intake. TNI of vitamin A reduced the proportion below
the EAR but also increased the proportion above the GL.
Partial correlations between intake and biomarkers
improved after the inclusion of supplement sources but
vitamin E intake exceeding food intake resulted in attenu-
ated coefficients, indicating minimal to no further
increase in the concentrations of the biomarkers studied.
This association was not observed for plasma EPA+DHA
concentrations.
We observed an upward shift of 0.1 lmol L1 in the
distribution of plasma retinol for the SU+A group versus
NSU and SU-A. The partial correlations between intake
and plasma were small, even among SU+A users. This is
in line with a review indicating that plasma retinol con-
centrations are not responsive to hypervitaminosis of vita-
min A (Penniston & Tanumihardjo, 2006). The
differential response of a- and c-tocopherol on vitamin E
supplementation has been found in clinical trials (Yoshik-
awa et al., 2005; Clarke et al., 2006). Supplements can
contain a mixture of tocopherols, although a-tocopherol
tends to dominate. a-Tocopherol transfer protein has
preferential incorporation of a-tocopherol into lipopro-
teins, which leads to increased metabolites of c-tocoph-
erol and hence a reduction of plasma c-tocopherol. A
meta-analysis of dose–response studies with either EPA or
DHA suggests that intakes of up to 4 g and 2 g, respec-
tively, show a clear linear association with biomarker
data; however, when supplemented together, this associa-
tion becomes less strong and only linear below
90th centile: 146; 99th centile: 433
90th centile: 148 99th centile: 395
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1.2 g day1 (Arterburn et al., 2006). In this observational
study, we found a weak but consistent association across
ranges of intakes from food and TNI that only in a small
proportion exceeded 1.2 g day1.
For the selection of nutrients studied, we found small
and mainly nonsignificant differences between the differ-
ent subgroups in intake distributions from food sources
only. Results from the UK Women’s Cohort Study have
shown that food nutrient intake among SU was higher
than among NSU (Kirk et al., 1999); however, the results
were obtained with a food frequency questionnaire and
are not suitable for comparison against diet reference
intakes. The British Birth Cohort used a 5-day diet diary
and observed that, even after adjustment for social class,
area of residence, smoking, alcohol and physical activity,
SU were proportionately more likely to be in the upper
tertile of food nutrient intake compared to NSU
(McNaughton et al., 2005). A comparison of the EPIC-
Norfolk nutrient intake with the 50–64-year-old category
of the 2000/2001 NDNS report (Henderson et al., 2003)
and 65–74-year-old category of the 1998 report (Finch
et al., 1998) show that the median food intakes of the
fat-soluble vitamins in EPIC-Norfolk were lower, with the
exception of vitamin A. The proportion estimated to have
food nutrient intake above 1400 lg RE day1 is 18%
among men and 8% among women; intakes above
1600 lg RE day1 are found for 13% and 7%, respec-
tively (Henderson et al., 2003). This range approximates
the 16.0% found in men in EPIC-Norfolk exceeding
1500 lg RE day1, although we found a higher preva-
lence (12.7%) among women. Both food and supplement
sources are able to exceed the GL intake and therefore we
have presented excess intakes for the subgroups sepa-
rately. We observed that 24–28% of the SU+A users had
a preformed retinol intake that exceeded the GL level and
could be at increased risk of bone fractures (Expert
Group on Vitamins and Minerals, 2003). In the 2003–06
data from the American National Health And Nutrition
Examination Survey (NHANES), where only preformed
retinol from supplement sources is considered a possible
risk, this percentage is 4–5% (Bailey et al., 2012). The
proportion of participants found at risk according to this
definition was similar for EPIC-Norfolk.
We quantified the association between intake and bio-
marker using both partial correlation and coefficients
from linear regression. Correlations between TNI and
plasma tocopherol found in this study were lower com-
pared to those found in other cohorts (White et al., 2001;
Satia-Abouta et al., 2003). This might be explained by the
higher proportion of high-dose (>400 mg day1) vitamin
E in these American cohorts, increasing a-tocopherol by
84% and decreasing c-tocopherol by 72% (White et al.,
2001). Considering the median supplement dose in EPIC-
Norfolk is below 10 mg day1 and because the correla-
tion coefficient is dependent on the range of the input
variables, we restricted the intake to a range known to be
linearly associated with plasma concentrations (Institute
of Medicine, 2000) and found that, among men, the
intake of food sources (NSU, SU-E), rather than TNI,
was more strongly associated with plasma tocopherols.
Among women, linear associations strengthened after the
inclusion of supplement sources. In line with White et al.
(2001), we found lower c-tocopherol concentrations at
relatively low vitamin E intakes (<17 mg day1); this
lower concentration might reduce the anti-inflammatory
and anti-oxidant function of c-tocopherol (Jiang et al.,
2001). Although we did not find strong linear associations
between vitamin D intake and serum 25(OH)D, among
SU+D we observed higher median 25(OH)D3 concentra-
tions and lower proportions of participants below the
tested hypovitaminosis thresholds. Also in the British
Birth Cohort, it was found that vitamin D supplements
reduced the risk of not attaining concentrations of
40 nmol L1 (Hypp€onen & Power, 2007).
In this analysis, statistical adjustment of the nutrient
distributions obtained was not attempted (National Can-
cer Institute, 2011). We acknowledge that more than
7 days of diet collection are necessary to obtain a precise
estimate of nutrient intake, particularly for vitamin A
(Nelson & Bingham, 1997). However, the main aim of
EPIC-Norfolk is to establish associations between diet
and chronic disease. The statistical methods applied for
this purpose often rely on ranking and less on absolute
intakes and so the inclusion of supplement sources, which
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Figure 5 Estimated marginal means and 95% confidence interval for
plasma eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) by
use of cod liver oil (CLO) and/or vitamin E supplements. The F-test for
interaction between CLO and vitamin E became nonsignificant after
inclusion of total nutrient intake (TNI) EPA+DHA intake as a
continuous variable (per 100 mg) (P = 0.129). aMeans were adjusted
for cholesterol, age, body mass index, alcohol consumption, smoking
and sex. *P < 0.05; *** P < 0.001; n.s., nonsignificant (Wald test,
after adjusting for TNI). NSU, nonsupplement users; E, vitamin E.
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will move SU to a higher rank, will have a stronger influ-
ence on the results than narrowing the distribution. Nev-
ertheless, measurement error could have overestimated
the proportions at risk of excessive intake. Although diary
data in our cohort can estimate a- or c-tocopherol sepa-
rately, many labels on manufacturers’ supplements were
not sufficiently detailed to establish the source; hence, we
were unable to ascertain the effects of the individual vita-
min E forms. Similar issues arose for vitamin D2 and
vitamin D3. For 75% of the supplements in the ViMiS
database, the form of vitamin D was not given by the
manufacturers; however, vitamin D found in CLO can be
assumed to be D3. Moreover, we did not observe a
decrease in serum 25(OH)D3, which has been shown to
occur when supplemented with D2 (Logan et al., 2013).
Manufacturer’s use of overages (Expert Group on Vita-
mins and Minerals, 2003), where a higher dose than sta-
ted on the packaging can be found in the supplement
consumed, could also have obscured our findings. Lastly,
our results were limited to subsets of the EPIC-Norfolk
population and, particularly for the vitamin D subset, the
number of participants in each supplement subgroup was
limited, ensuing wide confidence intervals for estimates.
Although intake in the SU+A group reduced the pro-
portion of participants not meeting the EAR to almost
0%, it increased daily intake above GL levels, which has
been associated with adverse health outcomes such as
lower bone density (Expert Group on Vitamins and Min-
erals, 2003). ‘More is better’ does not apply to all nutrient
intakes when related to their blood biomarker. Higher
intakes of the fat-soluble vitamins A and D were unre-
lated to biomarker status and vitamin E at intakes above
17 mg day1 became weakly associated with a-tocopherol
concentrations. From this perspective, there does not
appear to be any benefit of high-dose supplements, par-
ticularly for vitamin E, because ingestion of large quanti-
ties of a-tocopherol (the type mostly found in
supplements) can decrease c-tocopherol concentrations,
which might reduce anti-inflammatory capacity (Jiang
et al., 2001). Moreover, a meta-analysis has shown an
increased risk of mortality when supplementing vitamins
A and E (Bjelakovic et al., 2008).
Conclusions
From these results, we conclude that nutrient intake of
vitamins A, D and E, as well as EPA and DHA, is approxi-
mately doubled when subdividing SU into SU+ and SU
subgroups. However, although plasma concentrations tend
to be higher among SU+, the linear associations (with the
exception of EPA+DHA) are inconsistent across the sup-
plement subgroups, indicating that the supplement itself
had a minimal contribution to blood concentrations.
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